Institutional 13F Filings
Quarterly position changes from hedge funds and institutional investors.
RTW Investments Takes New Position in Waystar Holding Corp.
RTW Investments acquired 1.63 million shares of Waystar Holding Corp., marking a new stake in the company.
RTW Investments Increases Stake in Aquestive Therapeutics
RTW Investments boosted its position in Aquestive Therapeutics by 18.8%, now holding 7.43 million shares.
RTW Investments Opens New Stake in Aktis Oncology
RTW Investments has bought 1.59 million shares of Aktis Oncology, valued at $34.9 million.
RTW Investments Acquires New Stake in Candel Therapeutics
RTW Investments has taken a new stake in Candel Therapeutics, acquiring over 6.4 million shares.
RTW Investments Increases Castle Biosciences Holdings by 30%
RTW Investments added 643,098 shares in Castle Biosciences, now holding 2.76 million shares.
RTW Investments Increases Position in Replimune Group
RTW Investments adds 216,564 shares in Replimune Group, showing confidence in the biotech firm.
RTW Investments Reduces Stake in Taysha Gene Therapies
RTW Investments trimmed its Taysha Gene Therapies position by 2.72 million shares, reflecting a 16.6% reduction.
RTW Investments Increases Stake in Ultragenyx Pharmaceutical
RTW Investments boosted its Ultragenyx holdings by over 21% in its latest 13F filing.
RTW Investments Reduces Holdings in Zai Lab Limited
RTW Investments has trimmed its position in Zai Lab Limited by 5.5%, reflecting a strategic portfolio adjustment.
RTW Investments Increases Stake in Immatics N.V. by 12.6%
RTW Investments added 1.44 million shares of Immatics N.V., boosting its stake to 12.87 million shares.
RTW Investments Increases Stake in COMPASS Pathways
RTW Investments boosted its stake in COMPASS Pathways by 21.4%, adding 1.88 million shares.
RTW Investments Ups Stake in Repligen Corporation
RTW Investments increased its position in Repligen by 13.3%, now holding 1.21 million shares.
RTW Investments Increases Stake in Stoke Therapeutics
RTW Investments added 76,669 shares of Stoke Therapeutics, raising its total to 5.62 million shares.
RTW Investments Trims Cogent Biosciences Stake by 28.1%
RTW Investments reduced its stake in Cogent Biosciences, reflecting in its latest SEC filing.
RTW Investments Significantly Increases Stake in Erasca, Inc.
RTW Investments boosted its Erasca, Inc. position by over 16 million shares.
RTW Investments Increases Holdings in RadNet, Inc. (RDNT)
RTW Investments added 346,500 shares of RadNet, Inc., boosting its stake by 8.8%.
RTW Investments Boosts Stake in CG Oncology
RTW Investments significantly increased its holdings in CG Oncology, Inc., according to a recent SEC filing.
Intech Investment Management Boosts Stake in Commercial Metals Company
Intech Investment Management increased its holdings in Commercial Metals Company by 18.4%, reflecting confidence in the metal fabrication sector.
Avoro Capital Exits Ultragenyx Pharmaceutical Inc. Position
Avoro Capital Advisors has sold its entire stake in Ultragenyx Pharmaceutical Inc., according to a recent SEC filing.
Avoro Capital Advisors Sells Out of PTC Therapeutics
Avoro Capital Advisors has completely exited its stake in PTC Therapeutics.
Avoro Capital Advisors Sells Out of MoonLake Immunotherapeutics
Avoro Capital Advisors has completely exited its position in MoonLake Immunotherapeutics, selling all 2 million shares.
Avoro Capital Advisors Exits Sarepta Therapeutics Stake
Avoro Capital Advisors completely sold its Sarepta Therapeutics shares, removing 2.67 million shares from its portfolio.
Avoro Capital Advisors Exits Atrium Therapeutics Position
Avoro Capital Advisors has sold its entire stake in Atrium Therapeutics, exiting a 7.65 million share position.
Avoro Capital Advisors Exits Stake in Autolus Therapeutics
Avoro Capital Advisors sold its entire stake in Autolus Therapeutics, totaling 9.91 million shares.